These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9471929)

  • 1. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.
    Ryan DH; Crowther MA; Ginsberg JS; Francis CW
    Ann Intern Med; 1998 Feb; 128(4):270-6. PubMed ID: 9471929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty.
    Woolson ST; Zehnder JL; Maloney WJ
    J Arthroplasty; 1998 Feb; 13(2):207-10. PubMed ID: 9526216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
    Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
    Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
    Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
    Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia.
    Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG
    Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
    Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
    Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of screening compression ultrasonography and clinical examination for the diagnosis of deep vein thrombosis after total hip or knee arthroplasty.
    Robinson KS; Anderson DR; Gross M; Petrie D; Leighton R; Stanish W; Alexander D; Mitchell M; Mason W; Flemming B; Fairhurst-Vaughan M; Gent M
    Can J Surg; 1998 Oct; 41(5):368-73. PubMed ID: 9793503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement.
    Woolson ST
    J Bone Joint Surg Am; 1996 Nov; 78(11):1735-40. PubMed ID: 8934490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.
    Arsov T; Miladinova D; Spiroski M
    Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.